Show Summary Details
Page of

Mechano-sensitive channel blockers: a new class of antiarrhythmic drugs? 

Mechano-sensitive channel blockers: a new class of antiarrhythmic drugs?
Chapter:
Mechano-sensitive channel blockers: a new class of antiarrhythmic drugs?
Author(s):

Ed White

DOI:
10.1093/med/9780199570164.003.0065
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 18 November 2019

The activation of mechano-sensitive ion channels (MSC) has been implicated in the generation of stretch-activated cardiac arrhythmias, which are reported to be more prevalent in diseased tissue. MSC may also be involved in the remodelling process that occurs in response to chronic stress (e.g. hypertension) and strain (e.g. dilatation) overload. Thus the targeting of MSC would seem a valid goal for pharmacological intervention. However, it should also be noted that mechano-sensitivity is a property of most tissues and that in the heart it is associated with the normal regulation of contractility, Ca2+ handling, electrical activity and physiological growth.

This chapter discusses some of the factors that need to be resolved if the targeting of MSC, as a therapeutic tool, is to be achieved. For example, if an effective pharmacological strategy is to be devised for MSC their identity, structure and mode of gating, in human cardiac tissue, must be understood. Readers are also referred to reviews for further information on the pharmacology of MSC.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.